# FDA Inspection 1250166 - Bakul Pharma Private Limited - September 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/bakul-pharma-private-limited/f2a2b9ec-cb77-4b7f-9f90-9106d0cc8f7b
Source feed: FDA_Inspections

> FDA Inspection 1250166 for Bakul Pharma Private Limited on September 26, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250166
- Company Name: Bakul Pharma Private Limited
- Inspection Date: 2024-09-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1250166 - 2024-09-26](https://www.keypedia.com/records/fda_inspections/bakul-pharma-private-limited/e9471c75-340a-45b1-a31b-485c4700aab8)

Company: https://www.keypedia.com/companies/bakul-pharma-private-limited/7992578d-d445-4661-bfec-421f91e483e9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c